CD44 and cervical carcinoma: Notably, both cervical cancer and head and neck squamous cell carcinoma (HNSCC) frequently exhibit upregulation of CD44, largely driven by the oncogenic activity of high‐risk HPV E6 and E7 proteins [24, 107].